Serum apelin level predicts the major adverse cardiac events in patients with ST elevation myocardial infarction receiving percutaneous coronary intervention

Medicine (United States)

Volumn 94, Issue 4, 2015, Pages

  Liu, Hai Tao ^a   Chen, Mai ^a   Yu, Jin ^a   Li, Wei Jie ^a   Tao, Ling ^a   Li, Yan ^a   Guo, Wen Yi ^a   Wang, Hai Chang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; APELIN; C REACTIVE PROTEIN; CLOPIDOGREL; CREATINE KINASE MB; HEPARIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TIROFIBAN; TROPONIN I; APLN PROTEIN, HUMAN; BIOLOGICAL MARKER; CARDIOTONIC AGENT; SIGNAL PEPTIDE;

ARTICLE; BRAIN ISCHEMIA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY STENTING; FEMALE; FOLLOW UP; HEART DISEASE; HEART INFARCTION; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ANGIOCARDIOGRAPHY; BLOOD; CHINA; CORONARY ARTERY OCCLUSION; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; RADIOGRAPHY; STROKE;

BIOLOGICAL MARKERS; CARDIOTONIC AGENTS; CHINA; CHOLESTEROL, LDL; CORONARY ANGIOGRAPHY; CORONARY OCCLUSION; CREATINE KINASE, MB FORM; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; RECURRENCE; STROKE; TROPONIN I;

EID: 84938077784     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000449     Document Type: Article

References (26)

1. Barchielli A, Santoro GM, Balzi D, et al. Long-term prognosis after primary PCI in unselected patients with ST-elevation myocardial infarction. J Cardiovasc Med (Hagerstown). 2012; 13:819-827.
2. Kozuch M, Kralisz P, Korecki J., et al. Early and long-term prognosis of patients with coronary artery disease treated with percutaneous coronary interventions in 2005. Experience of single large-volume PCI center. Adv Med Sci. 2011; 56:222-230.
3. Hou X, Zeng H, He X., et al. Sirt3 is essential for apelin-induced angiogenesis in post-myocardial infarction of diabetes. J Cell Mol Med. 2014.
4. Li L, Zeng H, Hou X., et al. Myocardial injection of apelin-overexpressing bone marrow cells improves cardiac repair via upregulation of Sirt3 after myocardial infarction. PLoS One. 2013; 8:e71041.
5. Chandrasekaran B, Dar O, McDonagh T. The role of apelin in cardiovascular function and heart failure. Eur J Heart Fail. 2008; 10:725-732.
6. Dai T, Ramirez-Correa G, Gao WD. Apelin increases contractility in failing cardiac muscle. Eur J Pharmacol. 2006; 553:222-228.
7. Chong KS, Gardner RS, Morton J.J., et al. Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure. Eur J Heart Fail. 2006; 8:355-360.
8. Hou X, Hu Z, Xu H., et al. Advanced glycation endproducts trigger autophagy in cadiomyocyte via RAGE/PI3K/AKT/mTOR pathway. Cardiovasc Diabetol. 2014; 13:78.
9. Jia YX, Pan CS, Zhang J, et al. Apelin protects myocardial injury induced by isoproterenol in rats. Regul Pept. 2006; 133:147-154.
10. Japp AG, Newby DE. The apelin-APJ system in heart failure: pathophysiologic relevance and therapeutic potential. Biochem Pharmacol. 2008; 75:1882-1892.
11. Maguire JJ, Kleinz MJ, Pitkin S.L., et al. [Pyr1.]apelin-13 identified as the predominant apelin isoform in the human heart: vasoactive mechanisms and inotropic action in disease. Hypertension. 2009; 54:598-604.
12. Yi L, Hou X, Zhou J., et al. HIF-1alpha Genetic Variants and Protein Expression Confer the Susceptibility and Prognosis of Gliomas. Neuromolecular Med. 2014; 16:578-586.
13. Hou X, Hu Z, Huang X., et al. Serum osteopontin, but not OPN gene polymorphism, is associated with LVH in essential hypertensive patients. J Mol Med (Berl). 2014; 92:487-495.
14. Tycinska AM, Sobkowicz B, Mroczko B., et al. The value of apelin-36 and brain natriuretic peptide measurements in patients with first ST-elevation myocardial infarction. Clin Chim Acta. 2010; 411:2014-2018.
15. Kuklinska AM, Sobkowicz B, Sawicki R., et al. Apelin: a novel marker for the patients with first ST-elevation myocardial infarction. Heart Vessels. 2010; 25:363-367.
16. Zhang BH, Guo CX, Wang H.X., et al. Cardioprotective effects of adipokine apelin on myocardial infarction. Heart Vessels. 2014; 29:679-689.
17. Japp AG, Cruden NL, Barnes G, et al. Acute cardiovascular effects of apelin in humans: potential role in patients with chronic heart failure. Circulation. 2010; 121:1818-1827.
18. Zhang M, Mahoney E, Zuo T., et al. Protein kinase A activation enhances beta-catenin transcriptional activity through nuclear localization to PML bodies. PLoS One. 2014; 9:e109523.
19. Leeper NJ, Tedesco MM, Kojima Y, et al. Apelin prevents aortic aneurysm formation by inhibiting macrophage inflammation. Am J Physiol Heart Circ Physiol. 2009; 296:H1329-H1335.
20. Xu HY, Hou XW, Wang L.F., et al. Association between transforming growth factor beta1 polymorphisms and left ventricle hypertrophy in essential hypertensive subjects. Mol Cell Biochem. 2010; 335:13-17.
21. El-Shehaby AM, El-Khatib MM, Battah A.A., et al. Apelin: a potential link between inflammation and cardiovascular disease in end stage renal disease patients. Scand J Clin Lab Invest. 2010; 70:421-427.
22. Zeng XJ, Zhang LK, Wang H.X., et al. Apelin protects heart against ischemia/reperfusion injury in rat. Peptides. 2009; 30:1144-1152.
23. Hou XW, Son J, Wang Y., et al. Granulocyte colony-stimulating factor reduces cardiomyocyte apoptosis and improves cardiac function in adriamycin-induced cardiomyopathy in rats. Cardiovasc Drugs Ther. 2006; 20:85-91.
24. Hou XW, Wang LF, Wang N, et al. The G501C polymorphism of oxidized LDL receptor gene [OLR-1.] is associated with susceptibility and serum C-reactive protein concentration in Chinese essential hypertensives. Clin Chim Acta. 2008; 388:200-203.
25. Berry MF, Pirolli TJ, Jayasankar V, et al. Apelin has in vivo inotropic effects on normal and failing hearts. Circulation. 2004; 110:II187-II193.
26. Xu H, Hou X, Wang N., et al. Gender-specific effect of estrogen receptor-1 gene polymorphisms in coronary artery disease and its angiographic severity in Chinese population. Clin Chim Acta. 2008; 395:130-133.